NLRC5 Limits the Activation of Inflammatory Pathways
暂无分享,去创建一个
[1] Zhijian J. Chen,et al. NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways , 2010, Cell.
[2] P. Rosenstiel,et al. The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses , 2010, The Journal of Immunology.
[3] S. Girardin,et al. Unleashing the therapeutic potential of NOD-like receptors , 2009, Nature Reviews Drug Discovery.
[4] D. Philpott,et al. Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity1 , 2008, The Journal of Immunology.
[5] S. Benkő,et al. Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells , 2008, Molecular vision.
[6] D. Philpott,et al. NLRX1 is a mitochondrial NOD‐like receptor that amplifies NF‐κB and JNK pathways by inducing reactive oxygen species production , 2008, EMBO reports.
[7] Osamu Takeuchi,et al. MDA5/RIG-I and virus recognition. , 2008, Current opinion in immunology.
[8] G. Núñez,et al. RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.
[9] D. Goukassian,et al. IL‐10‐induced TNF‐alpha mRNA destabilization is mediated via IL‐10 suppression of p38 MAP kinase activation and inhibition of HuR expression , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] M. Braunstein,et al. The CATERPILLER Protein Monarch-1 Is an Antagonist of Toll-like Receptor-, Tumor Necrosis Factor α-, and Mycobacterium tuberculosis-induced Pro-inflammatory Signals* , 2005, Journal of Biological Chemistry.
[11] S. Girardin,et al. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals , 2005, Journal of endotoxin research.
[12] M. Kaplan,et al. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells , 2005, The Journal of experimental medicine.
[13] J. Ting,et al. CATERPILLER 16.2 (CLR16.2), a Novel NBD/LRR Family Member That Negatively Regulates T Cell Function* , 2005, Journal of Biological Chemistry.
[14] B. Foxwell,et al. Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle , 2004, Immunology.
[15] L. Csiba,et al. Transcriptional Regulation of Human CYP27 Integrates Retinoid, Peroxisome Proliferator-Activated Receptor, and Liver X Receptor Signaling in Macrophages , 2004, Molecular and Cellular Biology.
[16] F. Martinon,et al. NALPs: a novel protein family involved in inflammation , 2003, Nature Reviews Molecular Cell Biology.
[17] J. Trowsdale,et al. Genetic Control of MHC Class II Expression , 2002, Cell.
[18] J. Ting,et al. Mechanisms of Nuclear Import and Export That Control the Subcellular Localization of Class II Transactivator1 , 2001, The Journal of Immunology.
[19] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.
[20] B. Mach,et al. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.
[21] D. Philpott,et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.
[22] F. Sutterwala,et al. NLRC4/IPAF: a CARD carrying member of the NLR family. , 2009, Clinical immunology.
[23] J. Ting,et al. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.
[24] W. Reith,et al. The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.